Faculty Presenters

Issam Hamadeh, PharmD 

Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, NY

Dr. Issam Hamadeh is a Clinical Pharmacy Specialist for the multiple myeloma service at Memorial Sloan Kettering Cancer Center. He received his Doctor of Pharmacy degree from Purdue University, IN. After graduation, he completed a 3-year fellowship in Precision Medicine/Pharmacogenetics at the University of Florida, FL. Dr. Hamadeh is board certified in Oncology, and a member of several professional organizations. His clinical interests include supportive care, implementation of pharmacogenetics in hematology/oncology, and pharmacogenomics research.

Ashley Ames, MSN, RN, FNP-BC, OC 

Nurse Practitioner
Memorial Sloan Kettering Cancer Center
New York, NY

Ashley Ames is a family nurse practitioner on the outpatient lymphoma service at Memorial Sloan Kettering Cancer Center. She specializes in DLBCL, follicular lymphoma, chronic lymphocytic leukemia, and Hodgkin’s lymphoma.

Yi Lin, MD, PhD 

Assistant Professor of Oncology
Mayo Clinic College of Medicine and Science
Rochester, MN

Dr. Yi Lin is a professor of medicine with joint appointment in the Division of Hematology and Experimental Pathology at Mayo Clinic, Rochester, Minnesota.  Her practice is in lymphoma and myeloma.  She has an NIH-funded laboratory and clinical research program in biomarkers and immunotherapy. She is the PI and co-PI of multiple clinical trials testing novel dendritic cell vaccine combination immunotherapy and CAR-T therapy. 

She is the medical director for the Immune Effector Cell Program at Mayo Clinic, Rochester. As the Mayo Clinic Comprehensive Cancer Center Enterprise Deputy Director of Cancer Regenerative Biotherapeutics, and co-chair of the Experimental and Novel Therapeutics Disease Group, she also oversees the cancer cell therapy clinical research portfolio and practice across all three Mayo sites in Minnesota, Arizona, and Florida. She also co-chairs the International Myeloma Working Group (IMWG) Novel Immunotherapy Steering Committee and co-chairs the Society for Immunotherapy of Cancer (SITC) Myeloma Cancer Immunotherapy Guideline Subcommittee. 

Program Planning Commitee

Charie Gleason, MSN, NP-BC, AOCNP (Content Co-Chair)

VP and Chief APP Officer, Adjunct Faculty

Nell Hodgson Woodruff School of Nursing

Emory Healthcare

Atlanta, GA

Charise Gleason, MSN, NP-BC, AOCNP®, is the VP and Chief Advanced Practice Officer for Emory Healthcare and adjunct faculty at the Nell Hodgson Woodruff School of Nursing at Emory University. She has been a nurse practitioner in the Multiple Myeloma program at the Winship Cancer Institute of Emory University for over twenty years. She earned both her bachelor’s and master’s degrees from Emory University and holds an advanced oncology certification through the ONCC. Ms. Gleason has been an active presenter and educator on the topics of multiple myeloma and has authored or co-authored many publications, including book chapters, abstracts, articles for nursing journals, and scientific publications.

Jesus G. Berdeja, M.D. (Content Co-Chair)

Director of Multiple Myeloma Research

The Greco-Hainsworth Tennessee Oncology Centers for Research

Nashville, TN

Jesus G. Berdeja received his undergraduate degree from Stanford University and medical degree from Harvard University. He completed his internship and residency in the Department of Internal Medicine at the University of California in San Francisco and fellowships in medical oncology and hematology at Johns Hopkins University School of Medicine in Baltimore.

Dr. Berdeja specializes in clinical hematology, with a focus on multiple myeloma. Additionally, he is an active member of several professional organizations, including the International Myeloma Society, the American Society of Clinical Oncology, the American Society of Hematology, the International Myeloma Working Group and the Clinical Trials Myeloma Intergroup Committee. An active researcher, Dr. Berdeja has been the principal investigator many funded clinical trials in the field of multiple myeloma. He has published extensively in the peer-reviewed literature and is a frequent invited lecturer.

Nicole LeStrange, DNP, ANP-BC, AOCNP (Planner)

Nicole LeStrange serves as an Advanced Practice Provider (APP) manager at Memorial Sloan Kettering Cancer Center, where she oversees APPs in the Division of Hematologic Malignancies. She practices clinically as a nurse practitioner with the Bone Marrow Transplant Service.

Disclosures:

Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Other Contributors

All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.

Charise Gleason, MSN, NP-C, AOCNP discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months.

Jesús G. Berdeja, M.D. discloses contracted research with 2 Seventy Bio, Abbvie, Amgen, BMS, C4 Therapeutics, Caribou Biosciences, CARsgen, Cartesian Therapeutics, Celularity, CRISPR Therapeutics, Fate Therapeutics, Genentech, GSK, Ichnos Sciences, Incyte, Janssen, Juno Therapeutics, K36 Therapeutics. Karyopharm, Lilly, Novartis, Poseida, Roche, Sanofi, Takeda, Consulting Fee's with AstraZeneca, BMS, Caribou Biosciences, Galapagos, Janssen, K36 Therapeutics, Kite Pharma, Legend Biotech, Pfizer, Regeneron, Roche, Sanofi, Sebia, Takeda and Speaker's Honoria with Janssen during the past 24 months. 

Nicole Le Strange, DNP, ANP-BC, AOCNP discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months.

Ashley Ames, MSN, RN, FNP-BC, OCN discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months.

Issam Hamadeh, PharmD  discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months.

Yi Lin, MD, PhD